pharmacy

Ferosoft Fa SpecificationRequires Prescription (YES/NO)YesGenerics?Folic Acid , Iron Hydroxide Poly Maltose Complex Used ForAnaemiaHow it worksIn order to be bound to transferrin and ferritin, iron supplements must necessarily be in a Fe+3) level of oxidation. Iron is transported to the bone marrow as ferric ion (Fe+3) bound to transferrin and is reduced to theferrous form (Fe+2) for its release in the erythroid progenitor cells and is finally transferred to the protoporphyrin for the synthesis of hemoglobin.Folic acid is required for nucleoprotein synthesis and maintenance of normal erythropoiesis; precursor of tetrahydrofolic acid, which is necessary for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids.Ferosoft Fa Usage And SafetyDosage?Folic Acid , Iron Hydroxide Poly Maltose Complex Side EffectsThe side effects reported are occasional gastrointestinal irritation such as sensation of repletion, epigastric pain, nausea, constipation and diarrhea. There may be a dark coloration or black stools which is of no clinical significance. It does not cause teeth staining.Drug InteractionsPhenytoin , Sulfasalazine.IndicationIron (III)-hydroxide polymaltose complex + Folic acid are indicated for: - The treatment of latent iron deficiency. - Manifest iron deficiency. - Prophylactic therapy of iron and folic acid deficiency before during and after pregnancy (during lactation).When not to UseIron (III)-hydroxide polymaltose complex + Folic acid are contraindicated in patients:- Who show hypersensitivity to iron.- Receiving repeated blood transfusions.- With iron overload (e.g. hemochromatosis, hemosiderosis).- Who have disturbances in iron utilization (e.g. thalassemia, sidero-achrestic anemia, lead anemia).- Who have anemia not caused by iron deficiency (e.g. hemolytic anemia or megaloblastic anaemia caused by vitamin B12 deficiency)Ferosoft Fa PrecautionsPrecautionIn cases of anemia due to infections or malignancy, the substituted iron is stored in the reticulo-endithelial system, from which it is mobilized and utilized only after curing the primary disease.Ferosoft Fa WarningsWarning 1Since the iron is complex bound, ionic interactions with food components (phytin, oxalates, tannin etc.) and concomitant administration of drugs (tetracyclines, antacids) are unlikely to occur.Warning 2During pregnancy and lactation Iron (III)-hydroxide polymaltose complex + Folic acid should be used only if clearly required after consultation with the physician.Warning 3In case of overdosage, initially epigastric pain, diarrhea and vomiting can occur and may include metabolic acidosis, convulsions and coma after apparent recovery.Ferosoft Fa Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.

Ferotein-S Iv SpecificationRequires Prescription (YES/NO)YesGenericsIron sucroseUsed ForFluids & ElectrolytesHow it worksIron sucrose injection is in a class of medications called iron replacement products. It works?by replenishing iron stores?so that the body can make more red blood cells.Ferotein-S Iv Usage And SafetyDosageIron sucroseSide EffectsCommon: transient taste perversions (in particular metallic taste). Uncommon: headache, dizziness, hypotension and collapse, tachycardia, palpitations, bronchospasm, dyspnea, nausea, vomiting, abdominal pain, diarrhea pruritus, urticaria, rash, exanthema, erythema, muscle cramps, myalgia, fever, shivering, flushing, chest pain and tightness. Injection site disorders such as superficial phlebitis, burning, swelling. Rare: paresthesia, anaphylactoid reactions (rarely involving arthralgia), peripheral edema, fatigue, asthenia, malaise. Isolated cases: reduced level of consciousness, light-headed feeling, confusion, angioedema, swelling of joints, hyperhidrosis and back pain. Hemodialyis dependent-chronic kidney disease (HDD-CKD) patients: hypotension, muscle cramps, nausea, headache, graft complications, vomiting, dizziness, hypertension, chest pain and diarrhea. Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients: dysgeusia, peripheral edema, diarrhea, constipation, nausea, dizziness and hypertension . Patients receiving erythropoietin may experience: diarrhea, edema, nausea, vomiting, arthralgia, back pain, headache, hypertension, dysgeusia, dizziness, extremity pain and injection site burning. Peritoneal dialysis dependent-chronic kidney disease (PDD-CKD) patients: diarrhea, peritoneal infection, vomiting, hypertension, pharyngitis, peripheral edema and nausea.Drug InteractionsAs with all parenteral iron preparations, iron sucrose should not be administered concomitantly with oral iron preparations since the absorption of oral iron is reduced. Therefore, oral iron therapy should be started at least 5 days after the last injection of Iron Sucrose.IndicationIron sucrose is indicated for the treatment of iron deficiency in the following: - Where there is a clinical need to deliver iron rapidly to iron stores. - Patients who cannot tolerate oral iron therapy or who are noncompliant. - In active inflammatory bowel disease where oral iron preparations are ineffective. - Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients receiving an erythropoietin. - Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients not receiving an erythropoietin. - Hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin. - Peritoneal dialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietinWhen not to UseThe use of iron sucrose is contra-indicated in cases of: - Known hypersensitivity to iron sucrose or any of its components. - Anemias not attributable to iron deficiency. - Iron overload or disturbances in utilization of iron. - Patients with a history of asthma, eczema or other atopic allergy, because they are more susceptible to experience allergic reactions. - Pregnancy first trimester .Ferotein-S Iv PrecautionsPrecautionParenteral administered iron preparations can cause allergic or anaphylactoid reactions, which may be potentially fatal. Therefore, treatment for serious allergic reactions and facilities with the established cardio-pulmonary resuscitation procedures should be available.Ferotein-S Iv WarningsWarning 1In patients with liver dysfunction, parenteral iron should only be administered after careful risk/benefit assessment. Parenteral iron administration should be avoided in patients with hepatic dysfunction where iron overload is a precipitating factor, in particular Porphyria Cutanea Tarda (PCT). Careful monitoring of iron status is recommended to avoid iron overload . Warning 2Parenteral iron must be used with caution in case of acute or chronic infection. It is recommended that the administration of iron sucrose is stopped in patients with ongoing bacteremia. In patients with chronic infection a risk/benefit evaluation has to be performed, taking into account the suppression of erythropoiesis . Warning 3Hypotensive episodes may occur if the injection is administered too rapidly. Allergic reactions, sometimes involving arthralgia, have been more commonly observed when the recommended dose is exceeded . Ferotein-S Iv Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.